All In MedTech

Device Trial Radar · NCT04906707

Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease

Home-Based Intervention for Chronic Pain in Adults With Sickle Cell Disease (HIPAS)

Last checked: Nov 19, 2026Latest source record: Apr 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

44

Actual

Start

Oct 27, 2021

Primary completion

Mar 5, 2024

Study completion Mar 5, 2024

Sponsor

Lead sponsor
Emory UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Nursing Research (NINR)
First posted
May 28, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This project will evaluate AppliedVR's EaseVRx - a multi-modal, skills-based, 8-week, virtual reality, home intervention - in an exploratory randomized controlled trial for self-management of chronic pain among Black, young adults (ages 18-50) with sickle cell disease.

Conditions

  • Sickle Cell Disease

Interventions

  • EaseVRxDevice

    EaseVRx is a commercially available pain management program. It is a multi-modal, skills-based, 8-week, VR, mind-body approach to daily management of chronic pain that is designed for home use to be worn over the eyes. The program contains five types of modules that are as follows: Interoception, Education, 360-degree relaxation videos, Games, and Dynamic breathing. All program content is mapped to a therapeutically designed curriculum with weekly themes. The following core themes are infused into the curriculum: Acceptance, Attention shifting, Awareness, Rehabilitation, Self-compassion, Healthy Movement, Deep relaxation, Visualization, Knowledge of pain, Distraction, and Immersive enjoyment.

  • Audio-only version of EaseVRxBehavioral

    Participants in the control group will be asked to use the audio-only version of EaseVRx, which excludes references to visual content, to complete 7 sessions weekly. They will receive an electronic link to the recordings on SoundCloud (a music streaming platform) where they can choose to stream or download the audio recordings on their smartphone, laptop, or desktop computer.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain Rating Using Numerical Pain Rating Scale (NPRS)Time frame: Baseline, up to week 4 or time period 1 (day 1-28), from week 4 to 8 or time period 2 (days 29-56)
  2. Pain Intensity Subscale of the Chronic Pain Grade QuestionnaireTime frame: Baseline, week 4, week 8, and 4 weeks post-intervention (week 12)
  3. Participant Engagement: Minutes of Program Use Per DayTime frame: up to week 4 or time period 1 (day 1-28), from week 4 to 8 or time period 2 (days 29-56)

8 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Grady Memorial Hospital - Outpatient Sickle Cell Clinic

    Atlanta, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.